BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 24914740)

  • 21. Accuracy of point of care coagulometers compared to reference laboratory measurements in patients on oral anticoagulation therapy.
    Dillinger JG; Si Moussi T; Berge N; Bal Dit Sollier C; Henry P; Drouet L
    Thromb Res; 2016 Apr; 140():66-72. PubMed ID: 26901852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variation in warfarin dose adjustment practice is responsible for differences in the quality of anticoagulation control between centers and countries: an analysis of patients receiving warfarin in the randomized evaluation of long-term anticoagulation therapy (RE-LY) trial.
    Van Spall HG; Wallentin L; Yusuf S; Eikelboom JW; Nieuwlaat R; Yang S; Kabali C; Reilly PA; Ezekowitz MD; Connolly SJ
    Circulation; 2012 Nov; 126(19):2309-16. PubMed ID: 23027801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quality of INR control and switching to non-Vitamin K oral anticoagulants between women and men with atrial fibrillation treated with Vitamin K Antagonists in Spain. A population-based, real-world study.
    García-Sempere A; Hurtado I; Bejarano-Quisoboni D; Rodríguez-Bernal C; Santa-Ana Y; Peiró S; Sanfélix-Gimeno G
    PLoS One; 2019; 14(2):e0211681. PubMed ID: 30753227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of the mean time in the therapeutic INR range and the SAME-TT2R2 score in patients with atrial fibrillation and cognitive impairment.
    Gorzelak-Pabiś P; Zyzak S; Krewko Ł; Broncel M
    Pol Arch Med Wewn; 2016 Aug; 126(7-8):494-501. PubMed ID: 27511466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improving Anticoagulation Measurement Novel Warfarin Composite Measure.
    Razouki Z; Burgess JF; Ozonoff A; Zhao S; Berlowitz D; Rose AJ
    Circ Cardiovasc Qual Outcomes; 2015 Nov; 8(6):600-7. PubMed ID: 26420820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of the SAMe-TT2R2 score in a nationwide population of nonvalvular atrial fibrillation patients on vitamin K antagonists.
    Ruiz-Ortiz M; Bertomeu V; Cequier Á; Marín F; Anguita M
    Thromb Haemost; 2015 Oct; 114(4):695-701. PubMed ID: 26054407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Time in therapeutic range (TTR) and follow-up of patients on vitamin K antagonist: A cohort analysis].
    Valdelièvre E; Quéré I; Caré B; Laroche JP; Schved JF
    J Med Vasc; 2018 May; 43(3):155-162. PubMed ID: 29754725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-dose oral vitamin K is safe and effective for outpatient management of patients with an INR>10.
    Gunther KE; Conway G; Leibach L; Crowther MA
    Thromb Res; 2004; 113(3-4):205-9. PubMed ID: 15140584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determinants of oral anticoagulation control in new warfarin patients: analysis using data from Clinical Practice Research Datalink.
    Macedo AF; Bell J; McCarron C; Conroy R; Richardson J; Scowcroft A; Sunderland T; Rotheram N
    Thromb Res; 2015 Aug; 136(2):250-60. PubMed ID: 26073321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT₂R₂ score.
    Apostolakis S; Sullivan RM; Olshansky B; Lip GYH
    Chest; 2013 Nov; 144(5):1555-1563. PubMed ID: 23669885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assays of fibrin network properties altered by VKAs in atrial fibrillation - importance of using an appropriate coagulation trigger.
    Ząbczyk M; Blombäck M; Majewski J; Karkowski G; Wallen HN; Undas A; He S
    Thromb Haemost; 2015 Apr; 113(4):851-61. PubMed ID: 25518887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality of anticoagulation with warfarin in patients with nonvalvular atrial fibrillation in the community setting.
    Han SY; Palmeri ST; Broderick SH; Hasselblad V; Rendall D; Stevens S; Tenaglia A; Velazquez E; Whellan D; Wagner G; Heitner JF
    J Electrocardiol; 2013; 46(1):45-50. PubMed ID: 23063241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of the amiodarone-warfarin interaction on anticoagulation quality in a single, high-quality anticoagulation center.
    White RD; Riggs KW; Ege EJ; Petroski GF; Koerber SM; Flaker G
    Blood Coagul Fibrinolysis; 2016 Mar; 27(2):147-50. PubMed ID: 26258678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time in Therapeutic Range of Oral Vitamin K Antagonists in Hospitalized Elderly Patients.
    Lafarge L; Khayi F; Bel-Kamel A; Charhon N; Sarfati L; Falquet B; Ducher M; Bourguignon L
    Drugs Aging; 2018 Jun; 35(6):569-574. PubMed ID: 29882202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variability of INR and its relationship with mortality, stroke, bleeding and hospitalisations in patients with atrial fibrillation.
    Lind M; Fahlén M; Kosiborod M; Eliasson B; Odén A
    Thromb Res; 2012 Jan; 129(1):32-5. PubMed ID: 21851969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. International Normalized Ratio Variability: A Measure of Anticoagulation Quality or a Powerful Mortality Predictor.
    Vanerio G
    J Stroke Cerebrovasc Dis; 2015 Oct; 24(10):2223-8. PubMed ID: 26232891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Update on the control of patients on treatment with vitaminK antagonist oral anticoagulants in Primary Care].
    Fernández López P; López Ramiro MI; Merino de Haro I; Cedeño Manzano G; Díaz Siles FJ; Hermoso Sabio A
    Semergen; 2016; 42(8):530-537. PubMed ID: 26877111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identifying potential predictors of high-quality oral anticoagulation assessed by time in therapeutic international normalized ratio range: a prospective, long-term, single-center, observational study.
    Costa GL; Lamego RM; Colosimo EA; Valacio RA; Moreira Mda C
    Clin Ther; 2012 Jul; 34(7):1511-20. PubMed ID: 22717417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relation of the SAMe-TT2R2 score to quality of anticoagulation control and thromboembolic events in atrial fibrillation patients: Observations from the SPORTIF trials.
    Proietti M; Lane DA; Lip GY
    Int J Cardiol; 2016 Aug; 216():168-72. PubMed ID: 27156060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. INR variability in atrial fibrillation: a risk model for cerebrovascular events.
    Amouyel P; Mismetti P; Langkilde LK; Jasso-Mosqueda G; Nelander K; Lamarque H
    Eur J Intern Med; 2009 Jan; 20(1):63-9. PubMed ID: 19237095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.